Pernix Signs Agreement with Osmotica Pharmaceutical Corp to Promote KHEDEZLA (Desvenlafaxine ER) Tablets, 50 mg and 100 mg for Major Depressive Disorder

[Business Wire] – Pernix Therapeutics Holdings, Inc. , a specialty pharmaceutical company, today announced that it has signed an agreement with Osmotica Pharmaceuticals Corp to market and sell KHEDEZLAâ„¢ Extended-Release Tablets, 50 mg and 100 mg. more

View todays social media effects on PTX

View the latest stocks trending across Twitter. Click to view dashboard

See who Pernix is hiring next, click here to view